| 1 |
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
Aruna D. Pradhan et al. · New England Journal of Medicine
Open access |
5 Nov 2022 |
745 |
| 2 |
Essential role for proteinase-activated receptor-2 in arthritis
William R. Ferrell, John C. Lockhart, Elizabeth B. Kelso et al. · Journal of Clinical Investigation
Open access |
2003 |
335 |
| 3 |
Preparation of undegraded native molecular fibroin solution from silkworm cocoons
Hiromi Yamada, Hiroshi Nakao, Yoko Takasu et al. · Materials Science and Engineering C
|
Aug 2001 |
314 |
| 4 |
Plasma thrombomodulin in health and diseases
Shogo Takano, Shunsuke Kimura, Shinichi Ohdama et al. · Blood
Open access |
15 Nov 1990 |
302 |
| 5 |
Three‐dimensional spatial and temporal monitoring of soil water content using electrical resistivity tomography
Qi Zhou, Jun Shimada, Akira Sato · Water Resources Research
Open access |
Feb 2001 |
259 |
| 6 |
Dynamic Functional Relay between Insulin Receptor Substrate 1 and 2 in Hepatic Insulin Signaling during Fasting and Feeding
Naoto Kubota et al. · Cell Metabolism
Open access |
Jul 2008 |
250 |
| 7 |
Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial
Shun Ishibashi, Shizuya Yamashita, Hidenori Arai et al. · Atherosclerosis
Open access |
26 Feb 2016 |
216 |
| 8 |
Randomised clinical trial: Pemafibrate, a novel selective peroxisome proliferator‐activated receptor α modulator (SPPARMα), versus placebo in patients with non‐alcoholic fatty liver disease
Atsushi Nakajima, Yuichiro Eguchi, Masato Yoneda et al. · Alimentary Pharmacology & Therapeutics
Open access |
16 Sep 2021 |
211 |
| 9 |
Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trial
Shun Ishibashi, Hidenori Arai, Koutaro Yokote et al. · Journal of clinical lipidology
Open access |
28 Oct 2017 |
189 |
| 10 |
Effects of K-115 (Ripasudil), a novel ROCK inhibitor, on trabecular meshwork and Schlemm’s canal endothelial cells
Yoshio A. Kaneko, M Ohta, Toshihiro Inoue et al. · Scientific Reports
Open access |
19 Jan 2016 |
172 |
| 11 |
The Effect of Statins on mRNA Levels of Genes Related to Inflammation, Coagulation, and Vascular Constriction in HUVEC.
Shigeru Morikawa, Wakako Takabe, Chikage Mataki et al. · Journal of Atherosclerosis and Thrombosis
Open access |
2002 |
166 |
| 12 |
SLCO1B1 (OATP1B1, an Uptake Transporter) and ABCG2 (BCRP, an Efflux Transporter) Variant Alleles and Pharmacokinetics of Pitavastatin in Healthy Volunteers
Ichiro Ieiri, Suttasinee Suwannakul, Kazuya Maeda et al. · Clinical Pharmacology & Therapeutics
|
25 Apr 2007 |
164 |
| 13 |
Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial
Eiichi Araki, Shizuya Yamashita, Hidenori Arai et al. · Diabetes Care
|
3 Jan 2018 |
163 |
| 14 |
Rheology of Tear Film Lipid Layer Spread in Normal and Aqueous Tear–Deficient Dry Eyes
Norihiko Yokoi, Hideaki Yamada, Mizukusa Yutaka et al. · Investigative Ophthalmology & Visual Science
|
26 Nov 2008 |
148 |
| 15 |
Structure and Expression of cDNA for an Inhibitor of Blood Coagulation Isolated from Human Placenta: A New Lipocortin-Like Protein
Akio Iwasaki, Makoto Suda, Hiroshi Nakao et al. · The Journal of Biochemistry
|
Nov 1987 |
146 |
| 16 |
Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Hidenori Arai, Shizuya Yamashita, Koutaro Yokote et al. · Journal of Atherosclerosis and Thrombosis
Open access |
6 Apr 2018 |
137 |
| 17 |
One‐year clinical evaluation of 0.4% ripasudil (K‐115) in patients with open‐angle glaucoma and ocular hypertension
Hidenobu Tanihara, Toshihiro Inoue, Tetsuya Yamamoto et al. · Acta Ophthalmologica
Open access |
4 Sep 2015 |
136 |
| 18 |
Efficacy and safety of K-877, a novel selective peroxisome proliferator-activated receptor α modulator (SPPARMα), in combination with statin treatment: Two randomised, double-blind, placebo-controlled clinical trials in patients with dyslipidaemia
Hidenori Arai, Shizuya Yamashita, Koutaro Yokote et al. · Atherosclerosis
Open access |
24 Mar 2017 |
127 |
| 19 |
A selective ACAT-1 inhibitor, K-604, suppresses fatty streak lesions in fat-fed hamsters without affecting plasma cholesterol levels
Mami Ikenoya, Yasunobu Yoshinaka, Hideyuki Kobayashi et al. · Atherosclerosis
|
6 Jul 2006 |
127 |
| 20 |
Additive Intraocular Pressure–Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost
Hidenobu Tanihara, Toshihiro Inoue, Tetsuya Yamamoto et al. · JAMA Ophthalmology
|
16 Apr 2015 |
124 |
| 21 |
Effects of post-processing on cyclic fatigue response of a titanium alloy additively manufactured by electron beam melting
Shui Xiaoli, Kenta Yamanaka, Manami Mori et al. · Materials Science and Engineering A
|
19 Oct 2016 |
118 |
| 22 |
Intra‐ocular pressure‐lowering effects of a Rho kinase inhibitor, ripasudil (K‐115), over 24 hours in primary open‐angle glaucoma and ocular hypertension: a randomized, open‐label, crossover study
Hidenobu Tanihara, Toshihiro Inoue, Tetsuya Yamamoto et al. · Acta Ophthalmologica
Open access |
9 Dec 2014 |
117 |
| 23 |
Pemafibrate, a selective PPARα modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride content
Yusuke Sasaki, Masato Asahiyama, Toshiya Tanaka et al. · Scientific Reports
Open access |
8 May 2020 |
112 |
| 24 |
Effects of K-115, a Rho-Kinase Inhibitor, on Aqueous Humor Dynamics in Rabbits
Tomoyuki Isobe, Ken Mizuno, Yoshio A. Kaneko et al. · Current Eye Research
|
6 Feb 2014 |
105 |
| 25 |
Histone Deacetylase Inhibitor Reduces Monocyte Adhesion to Endothelium Through the Suppression of Vascular Cell Adhesion Molecule-1 Expression
Kenji Inoue, Mika Kobayashi, Kiichiro Yano et al. · Arteriosclerosis Thrombosis and Vascular Biology
Open access |
29 Sep 2006 |
105 |
| 26 |
Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Toshiaki Aoki, Hitoshi Nishimura, Shunji Nakagawa et al. · PubMed
|
Aug 1997 |
104 |
| 27 |
Hepatic Sdf2l1 controls feeding-induced ER stress and regulates metabolism
Takayoshi Sasako et al. · Nature Communications
Open access |
27 Feb 2019 |
104 |
| 28 |
Transporter-mediated influx and efflux mechanisms of pitavastatin, a new inhibitor of HMG-CoA reductase
Hideki Fujino, Tsuyoshi Saito, Shinichiro Ogawa et al. · Journal of Pharmacy and Pharmacology
|
Oct 2005 |
104 |
| 29 |
Automated segmentation of optic disc region on retinal fundus photographs: Comparison of contour modeling and pixel classification methods
Chisako Muramatsu, Toshiaki Nakagawa, Akira Sawada et al. · Computer Methods and Programs in Biomedicine
|
24 May 2010 |
101 |
| 30 |
Neuroprotective effect and intraocular penetration of nipradilol, a beta-blocker with nitric oxide donative action.
Ken Mizuno, Takaki Koide, Megumu Yoshimura et al. · PubMed
|
Mar 2001 |
99 |
| 31 |
Statins suppress apolipoprotein CIII-induced vascular endothelial cell activation and monocyte adhesion
Chunyu Zheng, Verónica Azcutia, Elena Aïkawa et al. · European Heart Journal
Open access |
26 Aug 2012 |
98 |
| 32 |
Metabolic properties of the acid and lactone forms of HMG-CoA reductase inhibitors
Hideki Fujino, Takashi Saito, Yoshihiko Tsunenari et al. · Xenobiotica
|
2004 |
98 |
| 33 |
Enhanced transdermal delivery of indomethacin-loaded PLGA nanoparticles by iontophoresis
Keishiro Tomoda, Hiroto Terashima, Kenichi Suzuki et al. · Colloids and Surfaces B Biointerfaces
|
23 Aug 2011 |
98 |
| 34 |
Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan
Masato Yoneda, Takuma Yamamoto, Yasushi Honda et al. · Journal of Gastroenterology
Open access |
3 Oct 2021 |
96 |
| 35 |
LR11, a Mosaic LDL Receptor Family Member, Mediates the Uptake of ApoE-Rich Lipoproteins In Vitro
Kouichi Taira, Hideaki Bujo, Satoshi Hirayama et al. · Arteriosclerosis Thrombosis and Vascular Biology
Open access |
Sep 2001 |
96 |
| 36 |
Aerobic Mineralization of Hexachlorobenzene by Newly Isolated Pentachloronitrobenzene-Degrading Nocardioides sp. Strain PD653
Kazuhiro Takagi, Akio Iwasaki, Ichiro Kamei et al. · Applied and Environmental Microbiology
Open access |
9 May 2009 |
96 |
| 37 |
Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: human UDP-glucuronosyltransferase enzymes involved in lactonization
Hideki Fujino, Iwao Yamada, Shunsuke Shimada et al. · Xenobiotica
|
2003 |
95 |
| 38 |
Effects of Acid and Lactone Forms of Eight HMG-CoA Reductase Inhibitors on CYP-Mediated Metabolism and MDR1-Mediated Transport
Toshiyuki Sakaeda, Hideki Fujino, Chiho Komoto et al. · Pharmaceutical Research
Open access |
31 Dec 2005 |
94 |
| 39 |
Effect of pitavastatin on apolipoprotein A-I production in HepG2 cell
Takashi Maejima, Hiroyuki Yamazaki, Taro Aoki et al. · Biochemical and Biophysical Research Communications
|
5 Oct 2004 |
94 |
| 40 |
Principles and development of spatial filtering velocimetry
Yoshihisa Aizu, T. Asakura · Applied Physics B
|
Aug 1987 |
94 |
| 41 |
Effect of Protease-Activated Receptor-2 Deficiency on Allergic Dermatitis in the Mouse Ear
Jun-ichi KAWAGOE, Toshiaki Takizawa, Jiro Matsumoto et al. · The Japanese Journal of Pharmacology
Open access |
2002 |
94 |
| 42 |
Expression and localization of P1 promoter-driven hepatocyte nuclear factor-4α (HNF4α) isoforms in human and rats
Shuying Sue Jiang, Toshiya Tanaka, Hiroko Iwanari et al. · Nuclear Receptor
Open access |
8 Aug 2003 |
92 |
| 43 |
Cross-enhancement of ANGPTL4 transcription by HIF1 alpha and PPAR beta/delta is the result of the conformational proximity of two response elements
Tsuyoshi Inoue et al. · Genome biology
Open access |
10 Apr 2014 |
86 |
| 44 |
Design and synthesis of highly potent and selective human peroxisome proliferator-activated receptor α agonists
Y. Yamazaki, Kazutoyo Abe, Tsutomu Toma et al. · Bioorganic & Medicinal Chemistry Letters
Open access |
25 May 2007 |
84 |
| 45 |
Comparative long‐term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20–40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia
Jakub Janusz Gumprecht, Masahiko Gosho, Dragos Budinski et al. · Diabetes Obesity and Metabolism
|
3 Aug 2011 |
83 |
| 46 |
Canine corneal thickness measured by ultrasonic pachymetry
Brian C. Gilger, R. David Whitley, Susan A. McLaughlin et al. · American Journal of Veterinary Research
Open access |
Oct 1991 |
80 |
| 47 |
Long-term safety and efficacy of tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, as monotherapy or in combination with other oral antidiabetic agents in Japanese patients with type 2 diabetes mellitus: multicenter, open-label, randomized controlled trials
Yukio Tanizawa, Kohei Kaku, Eiichi Araki et al. · Expert Opinion on Pharmacotherapy
|
11 Feb 2014 |
80 |
| 48 |
Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment
Koutaro Yokote, Shizuya Yamashita, Hidenori Arai et al. · International Journal of Molecular Sciences
Open access |
6 Feb 2019 |
79 |
| 49 |
Correlation of morphologic features of the iridocorneal angle to intraocular pressure in Samoyeds
Björn Ehesten, Kristina L. Narfström · American Journal of Veterinary Research
Open access |
Nov 1991 |
79 |
| 50 |
Relative Induction of mRNA for HMG CoA Reductase and LDL Receptor by Five Different HMG-CoA Reductase Inhibitors in Cultured Human Cells
Shigeru Morikawa, Michihisa Umetani, Shunji Nakagawa et al. · Journal of Atherosclerosis and Thrombosis
Open access |
2000 |
78 |